Skip to main content
Withdrawn

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days

By April 24, 2017No Comments

Condition

Neoplasms

Estimated Enrollment: 0

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: SS1PE-001|NCI Study # 01-C-0011

Study First Received: September 24, 2001

Last Updated: November 13, 2014

Estimated Primary Completion Date: null

 

Primary Outcome Measures:

Sponsors and Collaborators:

INSYS Therapeutics Inc

Website Link: https://ClinicalTrials.gov/show/NCT00024674

Leave a Reply